IRIS
VITA, GIANLUCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.884
NA - Nord America 2.838
AS - Asia 801
Continente sconosciuto - Info sul continente non disponibili 11
OC - Oceania 3
SA - Sud America 1
Totale 6.538
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.816
IE - Irlanda 897
CN - Cina 611
SE - Svezia 593
IT - Italia 432
PL - Polonia 296
DE - Germania 258
FI - Finlandia 120
GB - Regno Unito 102
SG - Singapore 84
UA - Ucraina 67
IN - India 66
FR - Francia 65
BE - Belgio 28
VN - Vietnam 20
MX - Messico 14
EU - Europa 9
CA - Canada 8
CZ - Repubblica Ceca 8
HK - Hong Kong 7
RU - Federazione Russa 5
ES - Italia 4
AT - Austria 3
KR - Corea 3
NL - Olanda 3
AU - Australia 2
IR - Iran 2
MY - Malesia 2
PH - Filippine 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
CH - Svizzera 1
CL - Cile 1
JP - Giappone 1
KZ - Kazakistan 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
RO - Romania 1
TW - Taiwan 1
Totale 6.538
Salva come PNG Salva come JPEG
Città #
Dublin 897
Chandler 624
Nyköping 380
Warsaw 296
Beijing 259
Jacksonville 234
Ashburn 217
Princeton 177
Medford 141
Ann Arbor 137
Cambridge 115
Messina 112
Des Moines 89
Boardman 63
Dearborn 62
Bremen 59
Lancaster 59
Shenyang 55
Pune 53
San Mateo 49
Singapore 48
Wilmington 43
New York 41
Jinan 39
Houston 31
Tianjin 31
Nanjing 29
Rome 29
Brussels 26
Hebei 23
Ningbo 23
Zhengzhou 23
Los Angeles 21
Dong Ket 20
Hangzhou 20
Nürnberg 17
Woodbridge 15
Munich 14
Palo Del Colle 13
Nanchang 12
Taizhou 12
Haikou 11
Hyderabad 11
Norwalk 11
Guangzhou 10
Helsinki 10
Changsha 9
Guadalupe 9
Jiaxing 8
Brno 7
Fuzhou 7
Hong Kong 7
Taiyuan 7
Riposto 6
Seattle 6
Ciudad Benito Juárez 5
Fairfield 5
Falls Church 5
Leawood 5
London 5
Catania 4
Fort Worth 4
Segrate 4
Taranto 4
Amsterdam 3
Augusta 3
Caserta 3
Clearwater 3
Glasgow 3
Hanover 3
Lanzhou 3
Mannheim 3
Milan 3
Monza 3
Napoli 3
Northampton 3
Nynäshamn 3
Piazza Armerina 3
San Antonio 3
Strasbourg 3
Toronto 3
Vienna 3
Washington 3
Xiangfen 3
Alicante 2
Ardabil 2
Bari 2
Batangas 2
Bergamo 2
Bologna 2
Cagliari 2
Dallas 2
Frosinone 2
Galluccio 2
Gizzeria 2
Kemerovo 2
Kuala Lumpur 2
Lappeenranta 2
Modena 2
Namdong-gu 2
Totale 4.860
Salva come PNG Salva come JPEG
Nome #
Severe rhabdomyolysis in a patient with “Heat Stroke” 192
6MWT performance correlates with peripheral neuropathy but not with cardiac involvement in patients with hereditary transthyretin amyloidosis (hATTR) 134
Parenteral nutrition improves nutritional status, autonomic symptoms and quality of life in transthyretin amyloid polyneuropathy 101
Health-related quality of life and functional changes in DMD: A 12-month longitudinal cohort study 91
Genetic Modifiers of Duchenne Muscular Dystrophy and Dilated Cardiomyopathy 89
Hippo signaling pathway is altered in Duchenne muscular dystrophy 85
Modulation of neuronal nitric oxide synthase and apoptosis by the isoflavone genistein in Mdx mice 74
Circulating miRNAs expression as potential biomarkers of mild traumatic brain injury 73
The soy isoflavone genistein blunts nuclear factor kappa-B, MAPKs and TNF-α activation and ameliorates muscle function and morphology in mdx mice. 72
Circulating microRNAs Profile in Patients With Transthyretin Variant Amyloidosis 71
Histological effects of givinostat in boys with Duchenne muscular dystrophy 70
Sport activity in Charcot-Marie-Tooth disease: A case study of a Paralympic swimmer 69
A Phase 1/2 Study of Flavocoxid, an Oral NF-κB Inhibitor, in Duchenne Muscular Dystrophy 69
Novel outcome measures for Charcot-Marie-Tooth disease: Validation and reliability of the 6-min walk test and StepWatch™ Activity Monitor and identification of the walking features related to higher quality of life 68
Integrated care of muscular dystrophies in Italy. Part 1. Pharmacological treatment and rehabilitative interventions 67
Effect of exercise on telomere length and telomere proteins expression in mdx mice 64
Telomere shortening is associated to TRF1 and PARP1 overexpression in Duchenne muscular dystrophy 64
ANT1 expression and RAGE-NF-kB pathway in sporadic inclusion body myositis. 63
Muscle Fat-Fraction and Mapping in Duchenne Muscular Dystrophy: Evaluation of Disease Distribution and Correlation with Clinical Assessments: A preliminary experience. 63
Psychological and practical difficulties among parents and healthy siblings of children with Duchenne vs. Becker muscular dystrophy: an Italian comparative study 63
Pilot study of flavocoxid in ambulant DMD patients. 63
Integrated care of muscular dystrophies in Italy. Part 2. Psychological treatments, social and welfare support, and financial costs 63
Telomere shortening and telomere-associated proteins in Duchenne muscular dystrophy. 62
The 24-month PUL changes and steroids correlation. 61
Effects of teriparatide on bone mineral density and quality of life in Duchenne muscular dystrophy related osteoporosis: a case report 61
Anabolic treatment with RHPTH of duchenne muscular dystrophy related osteoporosis: a case report 61
Intrathecal administration of Nusinersen in type 1 SMA: successful psychological program in a single Italian center 61
Pilot study of flavocoxid in ambulant DMD patients. 60
Nusinersen versus sham control in later-onset spinal muscular atrophy 60
Benefits of glucocorticoids in non-ambulant boys/men with Duchenne muscular dystrophy: A multicentric longitudinal study using the Performance of Upper Limb test 59
Pilot study of serial casting in muscular dystrophy patients. 59
Pilot study of serial casting of ankles in muscular dystrophy patients. 59
Outcome measures in Duchenne muscular dystrophy: validation of the Pediatric Quality of Life InventoryTM Neuromuscular Module in the Italian population and correlation with other functional assessments. 58
Genetic neuromuscular disorders: living the era of a therapeutic revolution. Part 1: peripheral neuropathies 58
Predictors of adaptation to non-invasive ventilation in neuromuscular disorders. 56
Predictors of adaptation to non-invasive ventilation in amyotrophic lateral sclerosis 56
First report of a family with a DMD out of frame exon 2 deletion associated with asymptomatic phenotypes. 55
Teriparatide (rhPTH 1-34) in Duchenne Muscular Dystrophy related osteoporosis: a case report 55
Modulation of neural nitric oxide synthase by the isoflavone genistein promotes muscle regeneration in mdx mice 55
Espressione di ANT1 e attivazione della via RAGE-NF-kB nella miosite a corpi inclusi. 54
24 month longitudinal data in ambulant boys with Duchenne muscular dystrophy. 54
MYH7-related myopathies: Clinical, histopathological and imaging findings in a cohort of Italian patients 54
Autonomic nervous system involvement in spinal muscular atrophy. 54
Severe rhabdomyolysis in a patient with “Heat Stroke” 53
Psycological status and emotional burden in amyotrophic lateral sclerosis caregivers: the role of metacognitive processes. 53
ANT1 is reduced in sporadic inclusion body myositis. 53
Which are the factors influencing NIV adaptation and tolerance in ALS patients? 53
First report of a family with a DMD out of frame exon 2 deletion associated with asymptomatic phenotypes. 51
Long term natural history data in ambulant boys with Duchenne muscular dystrophy: 36-month changes 50
Impaired myocardial deformation revealing subclinical left ventricular dysfunction in children with Duchenne dystrophy: a speckle tracking echocardiography study 50
Cardiac function in types II and III spinal muscular atrophy: should we change standards of care? 49
Genetic neuromuscular disorders: living the era of a therapeutic revolution. Part 2: diseases of motor neuron and skeletal muscle 49
Dolori muscolari, deficit di forza e/o disturbi sensitivi 49
Dual-echo dual flip angle gradient-echo MRI technique for quantification of muscle fat fraction in Duchenne muscular dystrophy: a new valuable outcome measure. 48
Telomere shortening and telomere associated proteins in exercised wild type and mdx mice. 48
Neuropsychological patter in centronuclear myopathy due to DNM2 gene mutations. 48
Miopatia prossimale in paziente con sindrome di Williams 47
Flavocoxid counteracts muscle necrosis and improves functional properties in mdx mice: a comparison study with methylprednisolone 47
Emergenze respiratorie nelle malattie neurologiche 47
Diagnosis of Duchenne Muscular Dystrophy in Italy in the last decade: Critical issues and areas for improvements 47
Pilot study of flavocoxid in ambulant DMD patients. 47
Impaired myocardial strain in early stage of Duchenne muscular dystrophy: its relation with age and motor performance 47
BONE INVOLVEMENT IN DUCHENNE MUSCULAR DYSTROPHY 46
6 Minute Walk Test in Duchenne MD Patients with Different Mutations: 12 Month Changes 45
FSHD and Williams syndrome: the occurrence of two genetic disorders due to heterozygous DNA fragment deletions in the same patient. 44
L'inibizione dei pathway del fattore nucleare-kappaB, delle MAP chinasi e di COX/5-LOX mediante trattamento con flavocoxid migliora la funzione e la morfologia muscolare nel topo mdx: uno studio comparativo con il metilprednisolone 44
Amyloid myopathy presenting with rhabdomyolysis. 44
Selective short-term verbal memory involvement in two siblings carrying centronuclear myopathy due to DNM2 gene mutations 44
Impaired rotational mechanics and strain revealing subclinical left ventricular dysfunction in children with Duchenne muscular dystrophy: a skeckle tracking study. 44
Burden, professional support, and social network in families of children and young adults with muscular dystrophies 44
Parenteral nutrition improves nutritional status, autonomic symptoms and qol in patients with TTR-FAP 44
Molecular profile of transthyretin related familial amyloidotic polyneuropathy: a microarray analysis 44
null 43
null 43
Psychosocial impact of presymptomatic genetic testing for transthyretin amyloidotic polyneuropathy 43
Psychosocial impact of presymptomatic genetic testing for amyloidotic polyneuropathy 43
Safety and effectiveness of ataluren: comparison of results from the STRIDE Registry and CINRG DMD Natural History Study 43
Impaired rotational mechanics and strain revealing subclinical left ventricular dysfunction in children with neuromuscolar disorders: a speckle tracking study 42
Psychosocial impact of sport activity in neuromuscular disorders 42
null 42
study of flavocoxid in ambulant DMD patients. 41
6 min walking test 12 month changes in DMD: Correlation with genotype. 41
Timed rise from floor as a predictor of disease progression in Duchenne muscular dystrophy: An observational study 41
Teriparatide (rhPTH 1-34) in Duchenne Muscular Dystrophy related osteoporosis: a case report. 41
Burden, social network and professional support in the families of patients with muscular dystrophies: results from the GUP10002 study. 41
Gene expression profile in transthyretin related familial amyloidotic polyneuropathy 40
Telomere shortening and telomere-associated proteins in Duchenne muscular dystrophy 40
Molecular profile of transthyretin related familial amyloidotic polyneuropathy: a microarray analysis. 40
Dolori muscolari, deficit di forza e/o disturbi sensitivi 40
microRNA-10 and -221 modulate differential expression of Hippo signaling pathway in human astroglial tumors 39
New aspects on patients affected by dysferlin deficient muscular dystrophy. 38
Longitudinal natural history in young boys with Duchenne muscular dystrophy 38
Role of calcineurin/NFAT on muscle regeneration in dystrophic process. 37
Molecular profile of transthyretin related familial amyloidotic polyneuropathy: a microarray analysis. 37
Stato dell'arte sulle terapie della Distrofia muscolare di Duchenne. 37
Clinical and pathological features of focal myositis 36
Regulation of SIRT1 in Duchenne Muscular Dystrophy by miRNA-34a. 36
Teriparatide (rhPTH) treatment in Duchenne Muscular Dystrophy, a case report. 36
Bone quality in Duchenne muscular dystrophy 36
The first report of a patient carrying an out-of-frame exon2 deletion in the dystrophin gene and showing a very unusual phenotype. 35
Totale 5.470
Salva come PNG Salva come JPEG
Categoria #
all - tutte 29.428
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.428
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020912 0 19 5 34 13 87 93 88 59 265 169 80
2020/2021932 54 47 212 39 237 52 74 41 22 80 36 38
2021/2022957 10 97 4 64 48 6 95 38 33 94 88 380
2022/20232.417 196 230 125 160 204 203 18 115 1.092 6 57 11
2023/2024734 31 116 35 83 55 176 37 41 5 32 25 98
2024/202592 61 31 0 0 0 0 0 0 0 0 0 0
Totale 6.876